Cargando…

Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation

Liver X receptor (LXR) agonism has theoretical potential for treating NAFLD/NASH, but synthetic agonists induce hyperlipidemia in preclinical models. Desmosterol, which is converted by Δ24‐dehydrocholesterol reductase (DHCR24) into cholesterol, is a potent endogenous LXR agonist with anti‐inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Enchen, Ge, Xiaoke, Nakashima, Hiroyuki, Li, Rumei, van der Zande, Hendrik J P, Liu, Cong, Li, Zhuang, Müller, Christoph, Bracher, Franz, Mohammed, Yassene, de Boer, Jan Freark, Kuipers, Folkert, Guigas, Bruno, Glass, Christopher K, Rensen, Patrick C N, Giera, Martin, Wang, Yanan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405065/ https://www.ncbi.nlm.nih.gov/pubmed/37357756 http://dx.doi.org/10.15252/emmm.202216845

Ejemplares similares

Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice
por: Ying, Zhixiong, et al.
Publicado: (2023)

Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70(−/−) mice by reducing fat absorption
por: Li, Rumei, et al.
Publicado: (2021)

Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles
por: Zhang, Boyan, et al.
Publicado: (2021)

DHCR24 exerts neuroprotection upon inflammation-induced neuronal death
por: Martiskainen, Henna, et al.
Publicado: (2017)

Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70(-/-) mice with human-like bile acids
por: de Vries, Hilde D., et al.
Publicado: (2022)

Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule
por: Wang, Miao, et al.
Publicado: (2013)

Identification and Characterization of 24-Dehydrocholesterol Reductase (DHCR24) in the Two-Spotted Cricket, Gryllus bimaculatus
por: Mack, Yin Shan Isa, et al.
Publicado: (2021)

Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect
por: Tamura, Satoru, et al.
Publicado: (2018)

Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway
por: Zhu, Wenqiang, et al.
Publicado: (2022)

Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C
por: Ezzikouri, Sayeh, et al.
Publicado: (2015)

Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning
por: Chan, Stephen L., et al.
Publicado: (2015)

Response to Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH
por: Ronda, Onne A.H.O., et al.
Publicado: (2022)

FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis
por: Liu, Cong, et al.
Publicado: (2023)

Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia
por: Kratzer, Adelheid, et al.
Publicado: (2009)

Metabolic Modeling Combined With Machine Learning Integrates Longitudinal Data and Identifies the Origin of LXR-Induced Hepatic Steatosis
por: van Riel, Natal A. W., et al.
Publicado: (2021)

Early but Not Late Exercise Training in Mice Exacerbates Hepatic Inflammation in Developing Nonalcoholic Fatty Liver Disease
por: Kovynev, Artemiy, et al.
Publicado: (2023)

The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis
por: Bai, Xiaojing, et al.
Publicado: (2022)

ODP037 Effects of DHCR24 Inhibitor on Excessive Adrenal Steroidogenesis in db/db mouse
por: Kamigaki, Risa, et al.
Publicado: (2022)

Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis
por: Feng, Ke, et al.
Publicado: (2021)

Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice
por: Yang, Jiufang, et al.
Publicado: (2023)

Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma
por: Dai, Miao, et al.
Publicado: (2017)

DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study
por: Liu, Xiao-Ping, et al.
Publicado: (2018)

Virtual Screening of Novel 24-Dehydroxysterol Reductase (DHCR24) Inhibitors and the Biological Evaluation of Irbesartan in Cholesterol-Lowering Effect
por: Wang, Haozhen, et al.
Publicado: (2023)

LXRα and LXRβ Nuclear Receptors Evolved in the Common Ancestor of Gnathostomes
por: Fonseca, Elza, et al.
Publicado: (2017)

High DHCR7 Expression Predicts Poor Prognosis for Cervical Cancer
por: Zou, Jing, et al.
Publicado: (2022)

DHCR7 Expression Predicts Poor Outcomes and Mortality from Sepsis
por: Guirgis, Faheem W., et al.
Publicado: (2023)

DHCR7 Expression Predicts Poor Outcomes and Mortality From Sepsis
por: Guirgis, Faheem W., et al.
Publicado: (2023)

Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)
por: Gilanchi, Samira, et al.
Publicado: (2014)

Dhcr24 activates the PI3K/Akt/HKII pathway and protects against dilated cardiomyopathy in mice
por: Dong, Wei, et al.
Publicado: (2018)

Cellular cholesterol loss by DHCR24 knockdown leads to Aβ production by changing APP intracellular localization
por: Huang, Yue, et al.
Publicado: (2023)

Gamma-Muricholic Acid Inhibits Nonalcoholic Steatohepatitis: Abolishment of Steatosis-Dependent Peroxidative Impairment by FXR/SHP/LXRα/FASN Signaling
por: Xie, Yang, et al.
Publicado: (2023)

Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches
por: Chen, Meimei, et al.
Publicado: (2018)

A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding
por: Paalvast, Yared, et al.
Publicado: (2022)

Age-dependent Increase in Desmosterol Restores DRM Formation and Membrane-related Functions in Cholesterol-free DHCR24(−/−) Mice
por: Kuehnle, Katrin, et al.
Publicado: (2009)

DHCR24 associates strongly with the endoplasmic reticulum beyond predicted membrane domains: implications for the activities of this multi-functional enzyme
por: Zerenturk, Eser J., et al.
Publicado: (2014)

Seladin-1/DHCR24 protects neuroblastoma cells against Aβ toxicity by increasing membrane cholesterol content
por: Cecchi, C, et al.
Publicado: (2008)

Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation
por: Wu, Jie, et al.
Publicado: (2020)

DPP4 Regulates DHCR24-Mediated Cholesterol Biosynthesis to Promote Methotrexate Resistance in Gestational Trophoblastic Neoplastic Cells
por: Yuan, Weijie, et al.
Publicado: (2021)

miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages
por: Vinod, Manjula, et al.
Publicado: (2014)

Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development
por: Zhou, Enchen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qeo80uhdqcpcj3r91he59f6b46